|
Journal of Histochemistry and Cytochemistry, Vol. 47, 1575-1580, December 1999, Copyright © 1999, The Histochemical Society, Inc.
Expression of the Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and the Matrix Metalloproteinase-2 in Bronchopulmonary and Breast Lesions
Stéphanie Caudroya,
Myriam Polettea,
Jean-Marie Tourniera,
Henriette Burleta,
Bryan Tooleb,
Stanley Zuckerc, and
Philippe Birembauta
a INSERM U 514, IFR 53, Laboratoire Pol Bouin, CHU de REIMS. Reims, France
b Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts
c Departments of Research and Medicine, Veterans Affairs Medical Center, Northport, New York
Correspondence to:
Myriam Polette, INSERM U 514, IFR 53, Laboratorie Pol Bovin, CHU de Reims, 45 rue Cognacq-Jay, 51100 Reims, France.
Tumor cells interact with stromal cells via soluble or cell-bound factors stimulating the production of matrix metalloproteinases (MMPs), a group of enzymes largely involved in the extracellular matrix (ECM) remodeling in tumor invasion. Among these factors, extracellular matrix metalloproteinase inducer (EMMPRIN) has been shown to stimulate in vitro the fibroblast production of various MMPs such as interstitial collagenase (MMP-1), stromelysin-1 (MMP-3), and gelatinase A (MMP-2). In this study, the EMMPRIN protein was detected by immunohistochemistry prominently in malignant proliferations of the breast and the lung. It was present at the surface of both tumor epithelial and peritumor stromal cells. Because previous studies have reported that stromal cells do not express EMMPRIN mRNAs, it is very likely that EMMPRIN is bound to stromal cells via a specific receptor. Moreover, our observations also demonstrated that the same peritumor stromal cells strongly express MMP-2. Our results show that EMMPRIN is an important factor in tumor progression by causing tumor-associated stromal cells to increase their MMP-2 production, thus facilitating tumor invasion and neoangiogenesis. (J Histochem Cytochem 47: 15751580, 1999)
Key Words:
metalloproteinases, tumor invasion, breast cancer, lung cancer

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev,
January 1, 2007;
87(1):
69 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Egawa, N. Koshikawa, T. Tomari, K. Nabeshima, T. Isobe, and M. Seiki
Membrane Type 1 Matrix Metalloproteinase (MT1-MMP/MMP-14) Cleaves and Releases a 22-kDa Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Fragment from Tumor Cells
J. Biol. Chem.,
December 8, 2006;
281(49):
37576 - 37585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tang, M. T. Nakada, P. Rafferty, J. Laraio, F. L. McCabe, H. Millar, M. Cunningham, L. A. Snyder, P. Bugelski, and L. Yan
Regulation of Vascular Endothelial Growth Factor Expression by EMMPRIN via the PI3K-Akt Signaling Pathway
Mol. Cancer Res.,
June 1, 2006;
4(6):
371 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. McDonnel Smedts and T.E. Curry Jr.
Expression of Basigin, an Inducer of Matrix Metalloproteinases, in the Rat Ovary
Biol Reprod,
July 1, 2005;
73(1):
80 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhou, C. Yu, X. Miao, Y. Wang, W. Tan, T. Sun, X. Zhang, P. Xiong, and D. Lin
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility
Carcinogenesis,
June 1, 2005;
26(6):
1117 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Goffin, I. C. Anderson, J. G. Supko, J. P. Eder Jr., G. I. Shapiro, T. J. Lynch, M. Shipp, B. E. Johnson, and A. T. Skarin
Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer
Clin. Cancer Res.,
May 1, 2005;
11(9):
3417 - 3424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tang, M. T. Nakada, P. Kesavan, F. McCabe, H. Millar, P. Rafferty, P. Bugelski, and L. Yan
Extracellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases
Cancer Res.,
April 15, 2005;
65(8):
3193 - 3199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, M. Tanino, K. Nagai, Y. Nasuhara, M. Nishimura, and R. M. Senior
Extracellular Matrix Metalloproteinase Inducer Is Increased in Smokers' Bronchoalveolar Lavage Fluid
Am. J. Respir. Crit. Care Med.,
July 15, 2003;
168(2):
222 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, K. Kadomatsu, G. L. Griffin, T. Muramatsu, and R. M. Senior
Increased Basigin in Bleomycin-Induced Lung Injury
Am. J. Respir. Cell Mol. Biol.,
May 1, 2003;
28(5):
600 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Nuttall, C. J. Pennington, J. Taplin, A. Wheal, V. W. Yong, P. A. Forsyth, and D. R. Edwards
Elevated Membrane-Type Matrix Metalloproteinases in Gliomas Revealed by Profiling Proteases and Inhibitors in Human Cancer Cells
Mol. Cancer Res.,
March 1, 2003;
1(5):
333 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Spinale
Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart
Circ. Res.,
March 22, 2002;
90(5):
520 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zucker, M. Hymowitz, E. E. Rollo, R. Mann, C. E. Conner, J. Cao, H. D. Foda, D. C. Tompkins, and B. P. Toole
Tumorigenic Potential of Extracellular Matrix Metalloproteinase Inducer
Am. J. Pathol.,
June 1, 2001;
158(6):
1921 - 1928.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 1999
|
|
|